FALLANI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 1.121
EU - Europa 748
AS - Asia 165
AF - Africa 3
Totale 2.037
Nazione #
US - Stati Uniti d'America 1.116
RU - Federazione Russa 265
PL - Polonia 260
IE - Irlanda 76
IT - Italia 56
CN - Cina 54
SE - Svezia 41
HK - Hong Kong 40
SG - Singapore 31
GB - Regno Unito 15
JO - Giordania 15
FI - Finlandia 12
IN - India 12
DE - Germania 10
VN - Vietnam 8
BE - Belgio 5
CA - Canada 5
TR - Turchia 5
CI - Costa d'Avorio 3
UA - Ucraina 3
ES - Italia 2
NL - Olanda 2
FR - Francia 1
Totale 2.037
Città #
Santa Clara 331
Warsaw 260
Chandler 103
Fairfield 103
Dublin 73
Ashburn 70
Seattle 59
Woodbridge 53
Wilmington 47
Cambridge 39
Houston 32
Ann Arbor 29
Beijing 27
Hong Kong 24
Singapore 24
Altamura 22
Lawrence 21
Buffalo 15
Princeton 15
Florence 14
Boston 13
Shanghai 13
Mumbai 11
San Diego 11
Dong Ket 8
Moscow 8
Boardman 5
Brussels 5
Izmir 5
Jacksonville 5
Medford 5
Falls Church 4
Helsinki 4
Toronto 4
Abidjan 3
Fiesole 3
Giugliano in Campania 3
London 3
Los Angeles 3
Barcelona 2
Bari 2
Boretto 2
Hounslow 2
Kent 2
New York 2
Norwalk 2
Phoenix 2
West Jordan 2
Yubileyny 2
Andover 1
Bremen 1
Clifton 1
Dongyang 1
Gloucester 1
Guangzhou 1
Hangzhou 1
Hillsboro 1
Huizhou 1
Leawood 1
Ludwigshafen am Rhein 1
Montevarchi 1
Munich 1
Nanning 1
Newark 1
Ottawa 1
Philadelphia 1
Redwood City 1
San Mateo 1
Seveso 1
Siena 1
Totale 1.518
Nome #
Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia. 273
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer. 229
Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary? 156
Auranofin and its Analogues Show Potent Antimicrobial Activity Covering Multiresistant Pathogens: Structure-Activity Relationships 149
Management of Meningitis Caused by Multi Drug-Resistant Acinetobacter Baumannii: Clinical, Microbiological and Pharmacokinetic Results in a Patient Treated with Colistin Methanesulfonate. 135
Daptomycin serum levels in critical patients undergoing continuous renal replacement 130
Caspofungin PK in critically ill patients after the first and fourth doses: suggestions for therapeutic drug monitoring? 122
Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections 116
Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration? 108
Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis 88
Chemioterapici Antimicrobici – Aminoglucosidi. 87
Plasma and intracellular pharmacokinetic (PK) study of prolonged infusion (PI) of gemcitabine (G) in combination with bolus cisplatin (C), in advanced nonsmall cell lung cancer: Preliminary results 79
Administering gemcitabine as fixed-dose-rate infusion in combination with cisplatin, potentially effective target plasma concentrations are achieved in patients with advanced non-small cell lung cancer 79
Aminoglucosidi 75
AMINOGLUCOSIDI 69
Pharmacokinetics and blister fluid penetration of ticarcillin/clavulanate in adults 60
Comparative in vitro activity of ciprofloxacin against methicillin-resistant staphylococci 59
In vitro effects of brodimoprim on human polymorphonuclear leukocyte functions. Preliminary results 50
Totale 2.064
Categoria #
all - tutte 5.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020213 0 0 0 0 0 34 31 34 39 35 33 7
2020/2021188 19 20 10 19 7 15 9 16 15 37 9 12
2021/2022127 2 14 6 2 15 7 3 8 8 3 25 34
2022/2023348 24 77 21 22 25 66 44 17 39 1 7 5
2023/2024129 9 11 21 3 14 17 8 24 5 10 3 4
2024/2025705 29 98 58 141 260 119 0 0 0 0 0 0
Totale 2.064